• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Activity of selected neutrophil enzymes of patients maintained on hemodialysis and treated with erythropoietin (rHu EPO)].

作者信息

Sułowicz W, Hanicki Z, Lisiewicz J, Kopeć A, Kraśniak A, Kuźniewski M, Kopeć J, Sydor A

机构信息

Kliniki Nefrologii AM w Krakowie.

出版信息

Pol Arch Med Wewn. 1991 Jun;85(6):391-5.

PMID:1896403
Abstract

The peroxidase, alkaline phosphatase, acid phosphatase, beta-glucuronidase and N-acetyl-beta-D-glucosaminidase activity was assessed using a semiquantitative cytochemical methods in peripheral blood neutrophils from 10 maintenance haemodialysed patients treated with recombinant human erythropoietin (rHu EPO) due to severe anaemia. The examination was performed immediately prior to rHu EPO treatment, after 10 weeks and 32 weeks of therapy. A statistically significant increase in the beta-glucuronidase and N-acetyl-beta-D-glucosaminidase activity was observed after 10 weeks, while all the enzymes studied except peroxidase showed a significant elevation of their activity after 32 weeks of the treatment as compared with the values obtained prior to therapy.

摘要

相似文献

1
[Activity of selected neutrophil enzymes of patients maintained on hemodialysis and treated with erythropoietin (rHu EPO)].
Pol Arch Med Wewn. 1991 Jun;85(6):391-5.
2
[Recombinant human erythropoietin stimulates synthesis of fetal hemoglobin in patients with renal anemia treated by repeated hemodialysis].[重组人促红细胞生成素刺激接受重复血液透析治疗的肾性贫血患者胎儿血红蛋白的合成]
Pol Arch Med Wewn. 1991 Jun;85(6):352-5.
3
[The effect of recombinant erythropoietin on candidicidal activity of polymorphonuclear leukocytes in hemodialyzed patients].
Cas Lek Cesk. 1995 Dec 6;134(23):756-9.
4
[Effect of recombinant human erythropoietin on the bone marrow picture in patients with chronic renal failure treated by hemodialysis].
Przegl Lek. 1992;49(3):88-90.
5
[Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].慢性血液透析患者中的重组人促红细胞生成素(rH-EPO)
Rev Med Chil. 1990 Jun;118(6):629-34.
6
Influence of recombinant human erythropoietin therapy on in vivo chemotaxis and in vitro phagocytosis of polymorphonuclear cells of hemodialysis patients.
Blood Purif. 1996;14(2):157-64. doi: 10.1159/000170257.
7
[Chemical structure, biotechnical production and clinical use of recombinant erythropoietin].[重组促红细胞生成素的化学结构、生物技术生产及临床应用]
Z Gesamte Inn Med. 1992 Jun;47(6):231-8.
8
Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices.用促红细胞生成素治疗与慢性肾衰竭相关的贫血:重组人红细胞生成素可能是现有选择中最好的。
Med Hypotheses. 2012 Jan;78(1):157-61. doi: 10.1016/j.mehy.2011.10.016. Epub 2011 Nov 10.
9
Effects of long-term treatment with recombinant human erythropoietin on physiologic inhibitors of coagulation.重组人促红细胞生成素长期治疗对生理性凝血抑制剂的影响。
Am J Nephrol. 1997;17(5):399-405. doi: 10.1159/000169130.
10
Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.接受重组人促红细胞生成素和 1-α-D3 治疗的维持性血液透析患者的淋巴细胞 5'-核苷酸酶和氨肽酶 N 活性
Ren Fail. 2005;27(3):283-8.